Rebecca Brinkschulte
- Biological Psychiatry top 2%
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms 2
- Immunology top 10%
- interferon and immune responses 3
- Nephrology top 5%
- Physiology top 5%
- Alzheimer's disease research and treatments 3
- Adenosine and Purinergic Signaling 1
- Calcium signaling and nucleotide metabolism 1
-
- Inflammasome and immune disorders 5
- Cell death mechanisms and regulation 1
-
- Advanced Glycation End Products research 2
Rebecca Brinkschulte
7 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Biological Psychiatry 247
- Neurology 430
- Immunology 387
- Nephrology 124
- Physiology 393
Countries citing papers authored by Rebecca Brinkschulte
This map shows the geographic impact of Rebecca Brinkschulte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Brinkschulte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Brinkschulte more than expected).
Fields of papers citing papers by Rebecca Brinkschulte
This network shows the impact of papers produced by Rebecca Brinkschulte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Brinkschulte. The network helps show where Rebecca Brinkschulte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rebecca Brinkschulte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 36 | |
| 2 | Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3breakdown → | 2022 | 178 |
| 3 | 2020 | 135 | |
| 4 | 2019 | 49 | |
| 5 | 2019 | 1 | |
| 6 | Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s diseasebreakdown → | 2017 | 708 |
| 7 | 2017 | 262 |
About Rebecca Brinkschulte
Rebecca Brinkschulte is a scholar working on Physiology, Clinical Biochemistry and Neurology, having authored 7 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), interferon and immune responses (3 papers), Alzheimer's disease research and treatments (3 papers), Advanced Glycation End Products research (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Adenosine and Purinergic Signaling (1 paper), Cell death mechanisms and regulation (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Biological Psychiatry (247 citations), Neurology (430 citations) and Immunology (387 citations). Rebecca Brinkschulte has collaborated with scholars based in Germany, United States and Norway. Frequent co-authors include Matthias Geyer, Eicke Latz, Bernardo S. Franklin, Michael T. Heneka, Dietmar Riedel, Carmen Venegas, Douglas T. Golenbock, Ellen Gelpí, Markus P. Kummer and Darío Tejera. Their work appears in journals such as Nature, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.